Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease?
Saved in:
| Title: | Apomorphine: A potential modifier of amyloid deposition in Parkinson's disease? |
|---|---|
| Authors: | Yarnall AJ; Institute of Neuroscience, Newcastle University, Newcastle, United Kingdom., Lashley T; The Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom., Ling H; Reta Lila Weston Institute of Neurological Studies, University College London, United Kingdom., Lees AJ; The Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom.; Reta Lila Weston Institute of Neurological Studies, University College London, United Kingdom., Coleman SY; Industrial Statistics Research Unit, Newcastle University, Newcastle, United Kingdom., O'Sullivan SS; Cork University Hospital, Cork, Ireland., Compta Y; Parkinson Disease and Movement Disorders Unit, Neurology Service, IDIBAPS, CIBERNED, Hospital Clinic, Barcelona, Catalonia, Spain., Revesz T; The Queen Square Brain Bank for Neurological Disorders, Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom., Burn DJ; Institute of Neuroscience, Newcastle University, Newcastle, United Kingdom. |
| Source: | Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2016 May; Vol. 31 (5), pp. 668-75. Date of Electronic Publication: 2015 Oct 13. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
